DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

H.C. Wainwright Maintains Buy on Taro Pharmaceutical Indus, Lowers Price Target to $94

H.C. Wainwright maintains Taro Pharmaceutical Indus (NYSE:TARO) with a Buy and lowers the price target from $110 to $94.

Benzinga · 02/04/2020 12:27

H.C. Wainwright maintains Taro Pharmaceutical Indus (NYSE:TARO) with a Buy and lowers the price target from $110 to $94.